Could a tiny implant cure your sleep apnea?
NCT ID NCT07243405
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device called the Lunair Alpha System, a neurostimulator implant that aims to treat moderate to severe sleep disordered breathing. It is for people who cannot use or do not tolerate other treatments like CPAP machines. The trial will check if the device is safe and improves breathing during sleep over 6 to 24 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- neurostimulator implant (Lunair Alpha System)
- What this could lead to
- If it works, this could offer a new treatment option for people with sleep apnea who cannot tolerate standard therapies like CPAP.
- What could go wrong
- This is an early study with only 45 people, so results may not apply to everyone. The implant requires surgery and carries risks like infection or device-related side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLEEP APNEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Paitilla
RECRUITINGPanama City, Provincia de Panamá, Panama
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could oxygen or a common drug fix Opioid-Linked sleep apnea?
- Personalized sleep apnea treatment on the horizon?
- Sleep apnea amino acid study pulled before it started
- New study tracks sleep quality at home during first weeks of CPAP therapy
- Heart patients may get sleep apnea test by mail in landmark trial
- Tiny electrode zaps tongue nerve to fight sleep apnea